# Bioequivalence Study of Levetiracetam Tablet and Intravenous Infusion in Healthy Japanese Subjects

> **NCT01394224** · PHASE1 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 25 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Levetiracetam
- **DRUG:** Levetiracetam

## Key facts

- **NCT ID:** NCT01394224
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2011-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01394224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01394224, "Bioequivalence Study of Levetiracetam Tablet and Intravenous Infusion in Healthy Japanese Subjects". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT01394224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*